Compliance With American Diabetes Association Treatment Guidelines for Adult Ketoacidosis
NCT ID: NCT00589680
Last Updated: 2024-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2007-12-31
2008-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of CBC as a Prognostic Marker for DKA Patients
NCT05666895
Diabetic Ketoacidosis: Brain Morphology and Cognition
NCT02443415
Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM)
NCT00970567
Diabetic Kidney Alarm (DKA) Study
NCT03128229
Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) Metabolism During Acute Hyperglycemia
NCT01178957
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2
Patients treated for DKA under DKA protocol implemented by hospital
No interventions assigned to this group
1
To establish a baseline on how patients are being treating with DKA in general and without a standardized DKA protocol
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \>/= 18 years of age
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marshall University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sharon Jones
Clinical Coordinator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sharon Jones, Pharm.D.
Role: PRINCIPAL_INVESTIGATOR
St. Mary's Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Mary's Medical Center
Huntington, West Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9137
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.